Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Polycomb group protein Mel18 inhibits hematopoietic stem cell self-renewal through repressing the transcription of self-renewal and proliferation genes.
Cai W, Liu X, Barajas S, Xiao S, Vemula S, Chen H, Yang Y, Bochers C, Henley D, Liu S, Jia Y, Hong M, Mays TM, Capitano ML, Liu H, Ji P, Gao Z, Pasini D, Wan J, Yue F, Platanias LC, Xi R, Chen S, Liu Y. Cai W, et al. Among authors: vemula s. Leukemia. 2024 Nov 19. doi: 10.1038/s41375-024-02462-w. Online ahead of print. Leukemia. 2024. PMID: 39562720
Knowledge and perception of a clinical trial among the participants: An experience from oral cholera vaccine study in Koshi Province, Nepal.
Chaudhary S, Uranw S, Rai B, Keshary Bhatta N, Shah GS, Poudel P, Khanal B, Shah Kalawar RP, Rai N, Shrestha J, Shrestha M, Parajuli S, Gupta BP, Vemula S, Rok Song K, Lynch J, Saluja T. Chaudhary S, et al. Among authors: vemula s. Hum Vaccin Immunother. 2024 Dec 31;20(1):2416760. doi: 10.1080/21645515.2024.2416760. Epub 2024 Oct 15. Hum Vaccin Immunother. 2024. PMID: 39410717 Free PMC article.
Randomized, open-label, phase 2 study of nivolumab plus ipilimumab or nivolumab monotherapy in patients with advanced or metastatic solid tumors of high tumor mutational burden.
Schenker M, Burotto M, Richardet M, Ciuleanu TE, Gonçalves A, Steeghs N, Schoffski P, Ascierto PA, Maio M, Lugowska I, Lupinacci L, Leary A, Delord JP, Grasselli J, Tan DSP, Friedmann J, Vuky J, Tschaika M, Konduru S, Vemula SV, Slepetis R, Kollia G, Pacius M, Duong Q, Huang N, Doshi P, Baden J, Di Nicola M. Schenker M, et al. Among authors: vemula sv. J Immunother Cancer. 2024 Aug 6;12(8):e008872. doi: 10.1136/jitc-2024-008872. J Immunother Cancer. 2024. PMID: 39107131 Free PMC article. Clinical Trial.
Baseline single institutional retrospective review of body mass index (BMI) as a prognostic indicator in patients with newly diagnosed glioblastoma (GBM).
Cappelli L, Uppendahl A, Gardner C, Khan M, Kayne A, Vemula S, Poiset SJ, Zhan T, Judy KD, Andrews DW, Simone NL, Alnahhas I, Shi W. Cappelli L, et al. Among authors: vemula s. J Clin Neurosci. 2024 Sep;127:110754. doi: 10.1016/j.jocn.2024.07.015. Epub 2024 Jul 27. J Clin Neurosci. 2024. PMID: 39068727
191 results